药不能停？药必须停？造影检查前二甲双胍停不(3)

1. Owen RJ, Hiremath S, Myers A, et al. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.Can Assoc Radiol J. 2014 ;65:96-105.

2. Tao SM, Wichmann JL, Schoepf UJ, et al. Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol. 2015 Dec 18. [Epub ahead of print]

3. Lencioni R, Fattori R, Morana G, et al. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study. Acta Radiol. 2010;51:741-50.

4. del Pozo-Fernández C, Pardo-Ruiz C, Sánchez-Botella C, et al. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients. Nefrologia. 2012;32:367-73.

5. Cayley WE Jr. Does metformin increase the risk of fatal or nonfatal lactic acidosis? Am Fam Physician. 2010;82:1068-70.

6. McCartney MM1, Gilbert FJ, Murchison LE, et al. Metformin and contrast media--a dangerous combination? Clin Radiol. 1999;54:29-33.

7. Shah AD, McHargue C, Yee J, et al. INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES. Endocr Pract. 2016;22:502-5.

8. Baerlocher MO, Asch M, Myers A. Five things to know about...metformin and intravenous contrast.CMAJ. 2013;185:E78.

9. DeFronzo R, Fleming GA, Chen K, et al. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016;65:20-9.

10. 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013版）. 中国糖尿病杂志2014;22:2-39.

11. 母义明,纪立农,宁光等.二甲双胍临床应用专家共识. 中国糖尿病杂志2014;22:673-681.